144 related articles for article (PubMed ID: 11998541)
21. A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients.
Sun HY; Chen YC; Wang YW; Gau CS; Chang SC
J Microbiol Immunol Infect; 2008 Apr; 41(2):151-9. PubMed ID: 18473103
[TBL] [Abstract][Full Text] [Related]
22. Pharmacoeconomics of adverse drug reactions.
Lundkvist J; Jönsson B
Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
[TBL] [Abstract][Full Text] [Related]
23. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
Tribiño G; Maldonado C; Segura O; Díaz J
Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
[TBL] [Abstract][Full Text] [Related]
24. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
25. Recognizing, reporting, and reducing adverse drug reactions.
Brown SD; Landry FJ
South Med J; 2001 Apr; 94(4):370-3. PubMed ID: 11332899
[TBL] [Abstract][Full Text] [Related]
26. [Drug intolerance caused by pseudo-allergic reactions].
Ring J
Wien Med Wochenschr; 1989 Apr; 139(6-7):130-4. PubMed ID: 2658340
[TBL] [Abstract][Full Text] [Related]
27. Paediatric adverse drug reaction reporting: understanding and future directions.
Carleton BC; Smith MA; Gelin MN; Heathcote SC
Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
[TBL] [Abstract][Full Text] [Related]
28. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
29. [Types of drug side effects and their classification].
Davydov VF
Farmakol Toksikol; 1980; 43(6):652-61. PubMed ID: 7450000
[TBL] [Abstract][Full Text] [Related]
30. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
von Euler M; Eliasson E; Ohlén G; Bergman U
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
[TBL] [Abstract][Full Text] [Related]
31. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
Jimmy B; Jose J; Rao PG
Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
[TBL] [Abstract][Full Text] [Related]
32. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
33. [Classification of drug-related problems].
Ruths S; Viktil KK; Blix HS
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3073-6. PubMed ID: 18049498
[TBL] [Abstract][Full Text] [Related]
34. Allergic drug reactions: identification and management.
Guill MF
Hosp Formul; 1991 Jul; 26(7):582-4, 587-9. PubMed ID: 10183505
[TBL] [Abstract][Full Text] [Related]
35. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
dos Santos DB; Coelho HL
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
[TBL] [Abstract][Full Text] [Related]
36. Adverse drug reactions in patients in an Iranian department of internal medicine.
Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
[TBL] [Abstract][Full Text] [Related]
37. Safety monitoring of drugs--where do we stand?
Palaian S; Mishra P; Shankar PR; Dubey AK; Bista D; Almeida R
Kathmandu Univ Med J (KUMJ); 2006; 4(1):119-27. PubMed ID: 18603884
[TBL] [Abstract][Full Text] [Related]
38. Readmissions and adverse drug reactions in internal medicine: the economic impact.
Dormann H; Neubert A; Criegee-Rieck M; Egger T; Radespiel-Tröger M; Azaz-Livshits T; Levy M; Brune K; Hahn EG
J Intern Med; 2004 Jun; 255(6):653-63. PubMed ID: 15147529
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for adverse drug reactions communication of the CHDM.
Hoigné R; Maibach R; Maurer P; Jaeger MD; Egli A; Galeazzi R; Hess T; Müller U; Kuenzi UP
Bratisl Lek Listy; 1991 Nov; 92(11):564-7. PubMed ID: 1806169
[TBL] [Abstract][Full Text] [Related]
40. Adverse drug reactions: types and treatment options.
Riedl MA; Casillas AM
Am Fam Physician; 2003 Nov; 68(9):1781-90. PubMed ID: 14620598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
